British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

In the chip sector, Broadcom (AVGO), Micron (MU), AMD (AMD), and Intel (INTC) traded lower last week. Traders took profits in ...

In the entertainment sector, Disney (DIS) is another winning stock. The firm reported revenue growth of 6.3% Y/Y to $22.57 ...

“Using Llama models running on Cerebras Inference, GSK is developing innovative AI applications, such as intelligent research ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...

The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

Durham non-profit among several to receive funding from GSK Denzel Washington rails against American politics: ‘You’re being ...

Durham Success Summit started five years ago and now many of the young men from the program have new careers outside Durham.

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

FTSE 100 and 250 decline as AstraZeneca and GSK weigh down. UK economy contracts in surprise September downturn, impacting growth prospects.